| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $6.5B | $6.8B | $9.4B | $8.9B | $1.7B | $1.4B | $6.9B |
| Cost of Revenue | $6.3B | $5.8B | $5.7B | $7.2B | $6.6B | $1.5B | $1.3B | $1.4B |
| Gross Profit | $0.5B | $0.7B | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B |
| Operating Income | $0.0B | $0.3B | $0.7B | $1.8B | $1.9B | $-0.7B | $0.2B | $0.7B |
| Net Income | $-0.1B | $0.1B | $0.5B | $1.3B | $1.3B | $-0.0B | $-0.1B | $0.1B |
| EPS (Basic) | $-0.88 | $0.92 | $3.66 | $9.16 | $8.15 | $-0.21 | $-0.49 | $0.32 |
| EPS (Diluted) | $-0.88 | $0.91 | $3.57 | $8.94 | $7.96 | $-0.21 | $-0.49 | $0.32 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.3B | $7.6B | $7.7B | $8.0B | $8.5B | $8.3B | $9.2B | $9.0B |
| Current Assets | $2.0B | $2.1B | $2.0B | $2.2B | $2.2B | $1.7B | $1.7B | $1.7B |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $5.5B | $5.5B | $5.4B | $5.5B | $5.9B | $6.8B | $6.8B | $6.2B |
| Current Liabilities | $1.6B | $1.6B | $1.5B | $1.6B | $1.7B | $1.2B | $1.1B | $1.1B |
| Stockholders' Equity | $1.8B | $2.0B | $2.2B | $2.5B | $2.7B | $1.5B | $2.4B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.5B | $1.0B | $1.9B | $1.7B | $0.4B | $0.6B | $0.9B |
| Investing Cash Flow | $-0.3B | $-0.3B | $-0.3B | $-0.3B | $-0.2B | $-0.8B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.7B | $-1.6B | $-1.6B | $0.4B | $-0.2B | $-0.6B |